Approval · Notice of Compliance 7120 · 2005

PRINIVIL: Notice of Compliance 7120

Issued June 22, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 7120
Date: June 22, 2005
Company: Merck Frosst Canada Ltd., Merck Frosst Canada Ltée
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Angiotensin converting enzyme inhibitor

Products in this notice

Brand	DIN	Status today
PRINIVIL	02240934	Cancelled Post Market
PRINIVIL	00839388	Cancelled Post Market
PRINIVIL	00839396	Cancelled Post Market
PRINIVIL	00839418	Cancelled Post Market
PRINIVIL	00839426	—
PRINIVIL	00839434	—

Medicinal ingredients

LISINOPRIL 2.5 MG per TAB
LISINOPRIL 5 MG per TAB
LISINOPRIL 10 MG per TAB
LISINOPRIL 20 MG per TAB
LISINOPRIL 40 MG per TAB
LISINOPRIL 80 MG per TAB